Literature DB >> 31759180

ICON: Diagnosis and management of allergic conjunctivitis.

Leonard Bielory1, Luis Delgado2, Constance H Katelaris3, Andrea Leonardi4, Nelson Rosario5, Pakit Vichyanoud6.   

Abstract

Ocular allergy (OA), interchangeably known as allergic conjunctivitis, is a common immunological hypersensitivity disorder affecting up to 40% of the population. Ocular allergy has been increasing in frequency, with symptoms of itching, redness, and swelling that significantly impacts an individual's quality of life (QOL). Ocular allergy is an often underdiagnosed and undertreated health problem, because only 10% of patients with OA symptoms seek medical attention, whereas most patients manage with over-the-counter medications and complementary nonpharmacological remedies. The clinical course, duration, severity, and co-morbidities are varied and depend, in part, on the specific ocular tissues that are affected and on immunologic mechanism(s) involved, both local and systemic. It is frequently associated with allergic rhinitis (commonly recognized as allergic rhino conjunctivitis), and with other allergic comorbidities. The predominance of self-management increases the risk of suboptimal therapy that leads to recurrent exacerbations and the potential for development of more chronic conditions that can lead to corneal complications and interference with the visual axis. Multiple, often co-existing causes are seen, and a broad differential diagnosis for OA, increasing the difficulty of arriving at the correct diagnosis(es). Ocular allergy commonly overlaps with other anterior ocular disease disorders, including infectious disorders and dry eye syndromes. Therefore, successful management includes overcoming the challenges of underdiagnosis and even misdiagnosis by a better understanding of the subtleties of an in-depth patient history, ophthalmologic examination techniques, and diagnostic procedures, which are of paramount importance in making an accurate diagnosis of OA. Appropriate cross-referral between specialists (allergists and eyecare specialists) would maximize patient care and outcomes. This would significantly improve OA management and overcome the unmet needs in global health.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31759180     DOI: 10.1016/j.anai.2019.11.014

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  12 in total

1.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

2.  Validation of the DECA criteria for allergic conjunctivitis severity and control.

Authors:  M Cesárea Sánchez-Hernández; Ana M Navarro; Joaquim Mullol; Antonio Valero; Carlos Colás; Alfonso Del Cuvillo; Joaquín Sastre
Journal:  Clin Transl Allergy       Date:  2020-10-23       Impact factor: 5.871

3.  Using the Internet Big Data to Investigate the Epidemiological Characteristics of Allergic Rhinitis and Allergic Conjunctivitis.

Authors:  Huijun Qiu; Rui Zheng; Xinyue Wang; Zhuanggui Chen; Peiying Feng; Xuekun Huang; Yuqi Zhou; Jin Tao; Min Dai; Lianxiong Yuan; Xiangdong Wang; Luo Zhang; Qintai Yang
Journal:  Risk Manag Healthc Policy       Date:  2021-05-06

4.  Frequency of incidental ocular findings during pre-employment screening at a tertiary care Eye hospital.

Authors:  Summaya Khan; Aisha Rafique; Omar Zafar
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

5.  Efficacy of montelukast in preventing seasonal recurrence of vernal keratoconjunctivitis in children.

Authors:  Apurva Hardas; Neera Singh; Amrita Mohanty; Srikant Kumar Sahu
Journal:  Eye (Lond)       Date:  2021-05-04       Impact factor: 4.456

6.  Synchronous Fluorescence as a Green and Selective Method for the Simultaneous Determination of Cetirizine and Azelastine in Aqueous Humor.

Authors:  Walaa Nabil Abd-AlGhafar; F A Aly; Zeinab A Sheribah; Samar Saad
Journal:  J Fluoresc       Date:  2022-03-28       Impact factor: 2.525

Review 7.  The Communication between Ocular Surface and Nasal Epithelia in 3D Cell Culture Technology for Translational Research: A Narrative Review.

Authors:  Malik Aydin; Jana Dietrich; Joana Witt; Maximiliane S C Finkbeiner; Jonas J-H Park; Stefan Wirth; Christine E Engeland; Friedrich Paulsen; Anja Ehrhardt
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

8.  Resolvin D2 and Resolvin D1 Differentially Activate Protein Kinases to Counter-Regulate Histamine-Induced [Ca2+]i Increase and Mucin Secretion in Conjunctival Goblet Cells.

Authors:  Menglu Yang; Nora Botten; Robin Hodges; Jeffrey Bair; Tor P Utheim; Charles N Serhan; Darlene A Dartt
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

9.  Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis.

Authors:  Jiayu Bao; Lei Tian; Yifan Meng; Binge Wu; Jingyi Wang; Jing He; Qiyan Shao; Chengshuo Wang; Ying Jie; Luo Zhang
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

10.  Effects of rAmb a 1-Loaded PLGA-PEG Nanoparticles in a Murine Model of Allergic Conjunctivitis.

Authors:  Hui Cao; Ling Liu; Junyi Wang; Miao Gong; Ruyi Yuan; Jiahua Lu; Xiaojun Xiao; Xiaoyu Liu
Journal:  Molecules       Date:  2022-01-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.